BioSpace News Archive

Business

Adaptimmune Marks Official Opening of U.K. Headquarters

Over 400 people will gather to celebrate the official opening of the flagship facility.

November 6, 2017

·

3 min read

Policy

First U.S. FDA Submission of Wearable Drug-Device Combination Product Based on Sensile Medical’s SensePatch Drug Delivery Technology

Under the Prescription Drug User Fee Act, the FDA has set an action date of June 23, 2018.

November 6, 2017

·

2 min read

Policy

Compugen to Initiate Manufacturing of COM902, its Lead Anti-TIGIT Monoclonal Antibody

Compugen today announced that it is advancing COM902, its lead anti-TIGIT antibody, into manufacturing in anticipation of filing an IND in 2019.

November 6, 2017

·

4 min read

Drug Development

Janssen R&D’s STELARA (ustekinumab) Shows Positive Results In Treatment of Systemic Lupus Erythematosus in Phase II Trial

The study met the primary endpoint, with a significantly higher proportion of patients in the STELARA group showing improvements in lupus disease activity as measured by the SLE Responder Index (SRI)-4 response at week 24, compared with patients receiving placebo.

November 6, 2017

·

14 min read

Drug Development

Samumed Announces Results of Phase II Trial of SM04690 Demonstrating Evidence of Cartilage Regeneration in Patients With Knee Osteoarthritis

Data support potential of SM04690 as a disease modifying drug for knee osteoarthritis.

November 6, 2017

·

3 min read

Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems

reatments delivered using linear accelerators including Algeria’s first TrueBeam systems are being delivered at Sidi-Bel-Abbes and Tlemcen Hospitals in the west of the country.

November 6, 2017

·

2 min read

Business

Eutilex and Huahai Enter Immuno-Oncology Partnership

Under the agreement, Huahai takes a $30M equity stake in Eutilex and receives an exclusive license to develop and commercialize EU-101.

November 6, 2017

·

5 min read

Drug Development

Flex Pharma Reports Positive Topline Data From Exploratory Phase II Trial of FLX-787 in ALS

The study was terminated early to focus the Company’s resources on the ongoing US Phase 2b ALS study (COMMEND).

November 6, 2017

·

7 min read

Drug Development

Tetra Discovery Partners Research Supports Ability of Novel Selective PDE4D Inhibitor, BPN14770, to Improve Memory and Cognition

BPN14770 is a highly selective inhibitor of PDE4D, which regulates brain signaling pathways involved in the early and late stages of memory formation.

November 6, 2017

·

5 min read

Business

Translate Bio Appoints Ann Barbier, M.D., Ph.D., as Chief Medical Officer

Translate Bio today announced the appointment of Ann Barbier, M.D., Ph.D., as chief medical officer, effective immediately.

November 6, 2017

·

2 min read